Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01201928 · ClinicalTrials.gov registry record
Pulmonary Function Substudy for Subjects Enrolled in Studies MKC-TI-161, MKC-TI-162 or MKC-TI-166
A clinical trial, sponsored by Mannkind Corporation.
- Terminated
- Registry status
- 3
- Enrollment target
NCT01201928 is a clinical trial that was terminated before completion, run by Mannkind Corporation. The registered enrollment target is 3 participants.
The verdict
NCT01201928 was terminated before completion, sponsored by Mannkind Corporation.
- TERMINATED
- Registry status
- 3 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate pulmonary function test (PFT) sub-study in interested subjects from studies MKC-TI-161, MKC-TI-162 and MKC-TI-166. 100 Type I and 100 Type II diabetics will be enrolled. Each subject will undergo 6 PFT assessments over the course of the parent study.
Interventions
- DRUG Technosphere Insulin Inhalation Powder
- DRUG Comparator administered in parent trial
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 3 participants |
| Start Date | 2010-10 |
| Est. Completion | 2012-03 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01201928
The ClinicalTrials.gov registry entry for NCT01201928 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 3 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Mannkind Corporation, which has 42 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Technosphere Insulin Inhalation Powder is the first listed.
NCT01201928 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01201928 about?
NCT01201928 is a clinical study titled "Pulmonary Function Substudy for Subjects Enrolled in Studies MKC-TI-161, MKC-TI-162 or MKC-TI-166". The purpose of this study is to evaluate pulmonary function test (PFT) sub-study in interested subjects from studies MKC-TI-161, MKC-TI-162 and MKC-TI-166. 100 Type I and 100 Type II diabetics will be enrolled. Each subject will undergo 6 PFT assessments over the course of the parent study.
What is the current status of trial NCT01201928?
This trial is currently terminated. The enrollment target is 3 participants. The study started on 2010-10. Estimated completion is 2012-03.
What interventions are being tested in trial NCT01201928?
The interventions under investigation include: Technosphere Insulin Inhalation Powder (DRUG), Comparator administered in parent trial (DRUG).
Who is sponsoring clinical trial NCT01201928?
This trial is sponsored by Mannkind Corporation, which has 42 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.